191 related articles for article (PubMed ID: 35121978)
1. Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma.
Alkallas R; Lajoie M; Moldoveanu D; Hoang KV; Lefrançois P; Lingrand M; Ahanfeshar-Adams M; Watters K; Spatz A; Zippin JH; Najafabadi HS; Watson IR
Nat Cancer; 2020 Jun; 1(6):635-652. PubMed ID: 35121978
[TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Lin J; Lin Y; Huang Z; Li X
Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
4. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
Phung B; Cieśla M; Sanna A; Guzzi N; Beneventi G; Cao Thi Ngoc P; Lauss M; Cabrita R; Cordero E; Bosch A; Rosengren F; Häkkinen J; Griewank K; Paschen A; Harbst K; Olsson H; Ingvar C; Carneiro A; Tsao H; Schadendorf D; Pietras K; Bellodi C; Jönsson G
Cell Rep; 2019 Jun; 27(12):3573-3586.e7. PubMed ID: 31216476
[TBL] [Abstract][Full Text] [Related]
5. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
6. Recurrent inactivating RASA2 mutations in melanoma.
Arafeh R; Qutob N; Emmanuel R; Keren-Paz A; Madore J; Elkahloun A; Wilmott JS; Gartner JJ; Di Pizio A; Winograd-Katz S; Sindiri S; Rotkopf R; Dutton-Regester K; Johansson P; Pritchard AL; Waddell N; Hill VK; Lin JC; Hevroni Y; Rosenberg SA; Khan J; Ben-Dor S; Niv MY; Ulitsky I; Mann GJ; Scolyer RA; Hayward NK; Samuels Y
Nat Genet; 2015 Dec; 47(12):1408-10. PubMed ID: 26502337
[TBL] [Abstract][Full Text] [Related]
7. SLURP-1 is mutated in Mal de Meleda, a potential molecular signature for melanoma and a putative squamous lineage tumor suppressor gene.
Bergqvist C; Kadara H; Hamie L; Nemer G; Safi R; Karouni M; Marrouche N; Abbas O; Hasbani DJ; Kibbi AG; Nassar D; Shimomura Y; Kurban M
Int J Dermatol; 2018 Feb; 57(2):162-170. PubMed ID: 29231248
[TBL] [Abstract][Full Text] [Related]
8. The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas.
Bhattacharya C; Wang X; Becker D
Mol Cancer; 2012 Nov; 11():82. PubMed ID: 23116066
[TBL] [Abstract][Full Text] [Related]
9. The Association of
Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
[TBL] [Abstract][Full Text] [Related]
10. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
Appenzeller S; Gesierich A; Thiem A; Hufnagel A; Jessen C; Kneitz H; Regensburger M; Schmidt C; Zirkenbach V; Bischler T; Schilling B; Siedel C; Goebeler ME; Houben R; Schrama D; Gehrig A; Rost S; Maurus K; Bargou R; Rosenwald A; Schartl M; Goebeler M; Meierjohann S
Cancer; 2019 Feb; 125(4):586-600. PubMed ID: 30561760
[TBL] [Abstract][Full Text] [Related]
11. Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma.
Zhang W; Kong Y; Li Y; Shi F; Lyu J; Sheng C; Wang S; Wang Q
Front Immunol; 2021; 12():798474. PubMed ID: 35087523
[TBL] [Abstract][Full Text] [Related]
12. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
13. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Li X; Cai Y
Aging (Albany NY); 2020 Aug; 12(16):16457-16475. PubMed ID: 32858528
[TBL] [Abstract][Full Text] [Related]
15.
Lin TC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
[TBL] [Abstract][Full Text] [Related]
16. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
17. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
Cursons J; Souza-Fonseca-Guimaraes F; Foroutan M; Anderson A; Hollande F; Hediyeh-Zadeh S; Behren A; Huntington ND; Davis MJ
Cancer Immunol Res; 2019 Jul; 7(7):1162-1174. PubMed ID: 31088844
[TBL] [Abstract][Full Text] [Related]
18. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
[TBL] [Abstract][Full Text] [Related]
20. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C
Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
